¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cross finger flap"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • spider finger
    °Å¹Ì¼Õ°¡¶ô
  • spring finger
    ¿ë¼öö¼Õ°¡¶ô
  • supernumerary finger
    °úÀ×¼Õ°¡¶ô
  • waxy finger
    ¹Ð¶ø¼Õ°¡¶ô
  • webbed finger
    ¹°°¥Äû¼Õ°¡¶ô
  • blue cross
    û½ÊÀÚ
  • criss-cross inheritance
    ½ÊÀÚÀ¯Àü, À̼ºÀ¯Àü
  • cross
    ±³Â÷
  • cross absorption
    ±³Â÷Èí¼ö
  • cross birth
    ȾÀ§ºÐ¸¸
  • cross bridge
    ±³Â÷°áÇÕ, ¿¬°á´Ù¸®
  • cross bridge cycle
    ±³Â÷°áÇÕÁÖ±â
  • cross circulation
    ±³Â÷¼øÈ¯
  • cross cylinder
    ±³Â÷¿øÁÖ·»Áî
  • cross fertilization
    ±³Â÷¼öÁ¤, Ÿ°¡¼öÁ¤
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • supernumerary finger
    °úÀ×¼Õ°¡¶ô
  • trigger finger
    ¹æ¾Æ¼è¼Õ°¡¶ô
  • waxy finger
    ¹Ð¶ø¼Õ°¡¶ô
  • webbed finger
    ¹°°¥Äû¼Õ°¡¶ô
  • gloved finger shadow
    Àå°©¼Õ°¡¶ô±×¸²ÀÚ
  • cross absorption
    ±³Â÷Èí¼ö
  • cross-modal association
    ±³Â÷½Ä¿¬ÇÕ
  • cross-reacting antibody
    ±³Â÷¹ÝÀÀÇ×ü
  • cross-reacting antigen
    ±³Â÷¹ÝÀÀÇ׿ø
  • blue cross
    û½ÊÀÚ
  • cross birth
    ³­»ê, ȾÀ§ºÐ¸¸
  • cross bridge
    ±³Â÷°áÇÕ, ¿¬°á´Ù¸®
  • cross
    ±³Â÷
  • cross-antigenicity
    ±³Â÷Ç׿ø¼º
  • cross-binding
    ±³Â÷¿¬°á
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • preauricular flap
    À̰³ÀüºÎÇÇÆÇ
  • radial forearm flap
    ¿ä°ñÀü¿ÏÇÇÆÇ
  • random cutaneous flap
    ÀÓÀÇÇÇÆÇ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • finger nail biting See nail biting
    ¼ÕÅé¾Ã±â.
  • finger nose test
    ¼Õ°¡¶ô-ÄÚ½ÃÇè. 1finger printing techniqueÀÇÁö¹®¹ý.
  • finger sucking See thumb sucking
    ¼Õ°¡¶ô»¡±â, ÈíÁöÁõ(ýåò¦ñø)
  • finger to nose test
    ¼Õ°¡¶ô-ÄÚ½ÃÇè.
  • first finger
    Á¦ ÀÏÁö, ¾öÁö ¼Õ°¡¶ô.
  • fourth finger
    ³Ý°(¹ÝÁö)¼Õ°¡¶ô, ¹«¸íÁö.
  • gloved finger shadow
    Àå°© ¼Õ°¡¶ô ¸ð¾ç
  • hammer finger
    Ãß»ó(÷ÙßÒ) ¼öÁö, ¸ÁÄ¡ ¼Õ°¡¶ô, Ãß»ó ¼Õ°¡¶ô, ÇØ¸Ó Çΰţ¬¸ÁÄ¡¡¡¼öÁö.
  • hammer finger
    Ãß»ó(÷ÙßÒ)¼öÁö, ¸ÁÄ¡¼Õ°¡¶ô, Ãß»ó¼Õ°¡¶ô, ÇØ¸ÓÇΰÅ.
  • hippocratic finger
    È÷Æ÷Å©¶óÅ×½º ¼Õ°¡¶ô.
  • index finger
    ÀÎÁö(ìÑò¦), ½ÃÁö(ãÆò¦), Áý°Ô(µÑ°) ¼Õ°¡¶ô, Á¦ÀÌ ¼öÁö(ð¯ì£â¢ò¦).
  • index finger
    Áý°Ô(µÑ°)¼Õ°¡¶ô, Á¦À̼öÁö(ð¯ì£â¢ò¦).
  • indexsecond finger
    Áý°Ô¼Õ°¡¶ô
  • jerk finger =trigger f.
    ¾àµ¿ ¼öÁö(å¸ÔÑâ¢ò¦), ¹æ¾Æ¼è ¼öÁö, ¹æ¾Æ¼è ¼Õ°¡¶ô.
  • latent finger-print
    ÇöÀåÁö¹®(úÞíÞò¦Ú£).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • two-factor cross
    ÀÌÀÎÀÚ ±³Â÷(ì£ì×í­Îßó©)
  • two-point cross
    ÀÌÁ¡±³Â÷(ì£ïÇÎßó©)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
F-N finger to nose
FPR false-positive rate; finger peripheral resistance; fluorescence photobleaching recovery; N-formylpep...
FSBP finger systolic blood pressure
FTN finger to nose
FVOP finger venous opening pressure
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
VWF Vibration white finger
ZF Zinc finger
ZFP Zinc finger proteins
VWF vibration induced white finger
ZNF zinc finger
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • pharyngeal flap
    ÀεΠÇÇÆÇ, ÀÎµÎÆí
  • regional pedicled flap
    ±¹¼Ò À¯°æ Á¶Á÷ÆÇ
  • renal capsular flap
    ½Å ÇǸ·Æí
  • rotation flap
    ȸÀü ÆÇ, ȸÀü ÇÇºÎÆÇ
  • skin flap
    ÇÇÆÇ, ÇÇºÎÆí
  • surgical flap
    ¿Ü°úÀû ÇÇºÎÆÇ
  • trapezoidal flap
    »ç¹æÇü Ä¡Àº ÆÇ¸·
  • trephination triangular flap
    »ï°¢Çü Ä¡Àº ÆÇ¸·
  • vascular flap
    Ç÷°üÇÇÆÇ
  • Widman type flap
    WidmanÇü ÇÇÆÇ
  • wound flap
    â¼ø
  • blue cross
    û½ÊÀÚ
  • cross
    ±³Â÷, ±³¹è, ±³Àâ
    ½ÊÀÚÀÇ Çüųª ±¸Á¶. ±³¹è¿¡ ÀÇÇØ ¸¸µé¾îÁø »ý¹°. ±³¹è ¹æ¹ý.
  • cross adaptation
    ±³Â÷ ¼øÀÀ
  • cross arch bar splint
    ¾Ç±³´ë ¿¬°á °íÁ¤ ÀåÄ¡
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
cross-linking reagent <chemistry> Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other.
(12 Dec 1998)
cross-matching 1. A test for incompatibility between donor and recipient blood, carried out prior to transfusion to avoid potentially lethal haemolytic reactions between the donor's red blood cells and antibodies in the recipient's plasma, or the reverse; performed by mixing a sample of red blood cells of the donor with plasma of the recipient (major crossmatch) and the red blood cells of the recipient with the plasma of the donor (minor crossmatch). Incompatibility is indicated by clumping of red blood cells and contraindicates use of the donor's blood.
2. In allotransplantation of solid organs (e.g., kidney), a test for identification of antibody in the serum of potential allograft recipients which reacts directly with the lymphocytes or other cells of a potential allograft donor; presence of these antibodies usually, if not always, contraindicates the performance of the transplantation because virtually all such grafts will be subject to a hyperacute type of rejection.
(05 Mar 2000)
cross-pollination <botany> Fertilization of a plant from a plant with a different genetic makeup.
(09 Oct 1997)
cross-reacting agglutinin An immune agglutinin specific for a group antigen.
Synonym: cross-reacting agglutinin.
(05 Mar 2000)
cross-reacting antibody <immunology> Antibody specific for group antigens, i.e., those with identical functional groups, antibody for antigens that have functional groups of closely similar, but not identical, chemical structure.
(05 Mar 2000)
cross-reacting material <haematology> A substance sufficiently different from a reference substance (R) to have a perceptibly different function from R but sufficiently similar to R that it reacts with anti-R antibodies; e.g., mutant factor VIII may be defective or even inert in coagulation and yet be immunologically identified as factor VIII.
(05 Mar 2000)
cross reaction <haematology, immunology> Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen.
(12 Dec 1998)
cross-reactive antibody <haematology, immunology> Antibodies which don't respond to any one specific antigen, but will respond to a number of them. These antibodies can be responsible for false positive results in antigen-antibody tests.
(09 Oct 1997)
cross-resistance <immunology, microbiology> Immunologic resistance to the pathogenic effects of a microorganism because of previous exposure to another species or type having cross reactive antigens.
This phenomenon is seen in microbes that acquire resistance to one drug through direct exposure and turn out to have resistance to one or more other drugs to which it has not been exposed. Cross-resistance arises because the mechanism of resistance to several drugs is the same and arises through the identical genetic mutations.
(09 Oct 1997)
cross-section <physics> Usually refers to the (apparent) area presented by a target particle to an oncoming particle (or electromagnetic wave). This measures the probability of an interaction occuring. For typical interactions between ions and electrons, or between two nuclei, these cross sections are generally measured in barns.
<anatomy> A transverse cut through a structure or tissue. The opposite of a cross-section is a longitudinal section. By analogy, a study may be cross-sectional or longitudinal.
(12 Dec 1998)
cross-sectional echocardiography two-dimensional echocardiography
cross-sectional method <epidemiology> The study of the life span involving comparison of groups of individuals at different age levels.
Compare: longitudinal method.
(05 Mar 2000)
cross-sectional study <epidemiology> A study in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with longitudinal studies which are followed over a period of time.
Synonym: horizontal study.
(18 Jul 2002)
cross-table lateral projection <radiology> Lateral projection radiography of a supine subject using a horizontal X-ray beam.
(05 Mar 2000)
cross tolerance <pharmacology> The resistance to one or several effects of a compound as a result of tolerance developed to a pharmacologically similar compound.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cross
    °Ç³Ê´Ù,Ⱦ´ÜÇÏ´Ù
  • cross-bar
    °¡·ÎÀå
  • cross-country
    µéÆÇÀ» °¡·ÎÁö¸£´Â
  • cross-examination
    ¹Ý´ë ½É¹®
  • cross-examine
    ¿¡ ¹Ý´ë ½É¹®ÇÏ´Ù
  • cross-eyed
    »çÆÈ¶ß±â
  • cross-grained
    °áÀÌ ºÒ±ÔÄ¢ÇÑ
  • cross-purpose
    ¹Ý´ëÀÇ ¸ñÀû
  • cross-question
    ¹Ý´ë ½É¹®
  • Celtic cross
    ÄÌÆ® ½ÊÀÚ°¡(Á߽ɿ¡ ringÀÌ ÀÖÀ½)
  • Charing Cross
    丵 Å©·Î½º(·±´ø½ÃÀÇ Áß¾Ó,Strand°¡ ¼­ÂÊ ³¡ÀÇ ¹øÈ­ ±¸¿ª)
  • Geneva cross
    Àû½ÊÀÚ
  • George Cross
    Á¶Áö ÈÆÀå(George 4¼¼¶§ Á¦Á¤ 1943)
  • Greek cross
    ±×¸®½º ½ÊÀÚ°¡
  • Green Cross Code
    ±¹¹Î Çлý¿ë ±³Åë ¾ÈÀü ±ÔÄ¢
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á